TCTR20210719006已完成2 期
Safety and Immunological Response following homologous or heterologous booster COVID-19 vaccination (3rd dose study) (extended study of Immunological Responses and safety after COVID-19 vaccination in Healthcare Workers at Siriraj Hospital, Bangkok)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •Males or females at least 18 years of age (inclusive)
- •- Have received 2nd dose of COVID-19 vaccine (CoronaVac or ChAdOx1) for 8-12 weeks earlier
- •- Can understand Thai language through speaking, reading and writing
- •- Able to communicate through electronic tools such as Google form or line
- •- Capable of attending all study visits according to the study schedule
- •- Capable of informed consent and provision of written informed consent before any study procedures
排除标准
- •- Have history of severe drug or vaccine allergy (anaphylaxis)
- •- Have detected COVID-19 infection within the last 90 days
- •- Have received blood transfusion, plasma, blood product, blood components, immunoglobulins, antiviral or antibodies within the last 90 days
- •- Have history of cigarettes smoking, alcohol drinking and history of drug abuse
- •- Be pregnant
- •- Have unstable disease or could not control the symptom
- •- Have history of immunodeficiency or use immunosuppressant or steroid drugs
- •- Have any unusual symptoms or medical history that considered unable to participate in the study
研究者
相似试验
Enrolling By Invitation
2 期
Safety and Immunological Response following heterologous prime-boost primary series and booster COVID-19 vaccinatioHealthy volunteersheterologous prime-boostCOVID-19 vaccineTCTR20210720007Faculty of Medicine Siriraj Hospital270
已完成
不适用
Immunogenicity and Safety Outcome of Homologous and Heterologous Prime-boost of Inactivated Vaccine and Replication-defective Viral Vectors Vaccine Against SARS-CoV2 among Hemodialysis Patients: An Observational Prospective Cohort TrialTCTR20220516002Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand130
招募中
4 期
Immunologic response to hepatitis B immunization in children post liver transplantatioSafety and efficacy of hepatitis B vaccine, standard compare to double dose in short and long term follow-up.infection, bleeding, painTCTR20180723002Chulalonkorn University72
Unknown
3 期
BNT162b2 in Thai childreImmunization to prevent COVID-19 infection.COVID-19, vaccination, BNT162b2, children, liver transplant, immunogenicity, safetyTCTR20220708003Chulalongkorn University33
招募中
3 期
Safety, humoral and cellular immunogenicity after coronavirus disease-19 (COVID-19) vaccination (BNT162b2) in 12 to 18 year-old children after liver transplantatioImmunization to prevent COVID-19 infectionCOVID-19, vaccination, BNT162b2, adolescent, liver transplant, immunogenicity, safetyTCTR20210830002Chulalongkorn university44